Total Payments
$15,714
2024 Payments
$1,479
Companies
65
Transactions
1,176
Medicare Patients
22,342
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$15,399 (98.0%)
Education$296.69 (1.9%)
Other$18.80 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,399 | 1,167 | 98.0% |
| Education | $296.69 | 8 | 1.9% |
| Debt forgiveness | $18.80 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,657 | 143 | $0 (2024) |
| Novo Nordisk Inc | $1,223 | 121 | $0 (2024) |
| Lilly USA, LLC | $1,198 | 112 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,028 | 55 | $0 (2024) |
| Allergan, Inc. | $951.79 | 90 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $871.94 | 64 | $0 (2024) |
| GlaxoSmithKline, LLC. | $629.44 | 57 | $0 (2023) |
| Abbott Laboratories | $596.32 | 32 | $0 (2024) |
| PFIZER INC. | $585.85 | 48 | $0 (2024) |
| Amgen Inc. | $579.62 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,479 | 101 | ABBVIE INC. ($229.78) |
| 2023 | $2,412 | 155 | AbbVie Inc. ($478.26) |
| 2022 | $2,226 | 172 | ABBVIE INC. ($348.71) |
| 2021 | $2,394 | 170 | AbbVie Inc. ($475.11) |
| 2020 | $1,846 | 137 | Allergan, Inc. ($397.70) |
| 2019 | $1,498 | 121 | Novo Nordisk Inc ($157.98) |
| 2018 | $1,573 | 133 | Novo Nordisk Inc ($240.35) |
| 2017 | $2,285 | 187 | Allergan Inc. ($344.82) |
All Payment Transactions
1,176 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Endocrinology | ||||||
| 12/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neuroscience | ||||||
| 10/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes Care | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: PAIN | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 60 | 6,383 | 10,766 | $753,437 | $374,146 |
| 2022 | 57 | 5,844 | 9,828 | $675,282 | $316,849 |
| 2021 | 54 | 5,201 | 9,336 | $633,042 | $267,186 |
| 2020 | 48 | 4,914 | 8,292 | $594,116 | $252,396 |
Total Patients
22,342
Total Services
38,222
Medicare Billing
$1.2M
Procedure Codes
219
All Medicare Procedures & Services
219 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 648 | 1,546 | $154,600 | $86,851 | 56.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 212 | 212 | $68,900 | $59,047 | 85.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 211 | 1,333 | $99,975 | $57,375 | 57.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 392 | 392 | $92,512 | $48,843 | 52.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 60 | 68 | $17,440 | $13,272 | 76.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 187 | $28,798 | $13,027 | 45.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 165 | 167 | $13,345 | $11,858 | 88.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 504 | 832 | $8,320 | $6,964 | 83.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 360 | 360 | $10,800 | $6,383 | 59.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 40 | 40 | $11,360 | $6,264 | 55.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 210 | 210 | $6,300 | $6,174 | 98.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 37 | 37 | $10,508 | $5,923 | 56.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 462 | 555 | $47,175 | $5,625 | 11.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 381 | 424 | $22,048 | $5,437 | 24.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 168 | 170 | $5,100 | $4,998 | 98.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 200 | 240 | $15,120 | $3,887 | 25.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 193 | 352 | $13,376 | $3,306 | 24.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 261 | 315 | $9,450 | $2,351 | 24.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 179 | 280 | $18,200 | $2,306 | 12.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $2,975 | $2,215 | 74.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 45 | 56 | $8,736 | $2,107 | 24.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 111 | 111 | $8,880 | $2,062 | 23.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 36 | 36 | $3,600 | $1,792 | 49.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 69 | 75 | $5,625 | $1,596 | 28.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 124 | 172 | $6,880 | $1,490 | 21.7% |
About Dr. Bryan Bowen, MD
Dr. Bryan Bowen, MD is a Family Medicine healthcare provider based in Wake Village, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770578072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Bowen, MD has received a total of $15,714 in payments from pharmaceutical and medical device companies, with $1,479 received in 2024. These payments were reported across 1,176 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($15,399).
As a Medicare-enrolled provider, Bowen has provided services to 22,342 Medicare beneficiaries, totaling 38,222 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 219 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wake Village, TX
- Active Since 09/13/2005
- Last Updated 06/13/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1770578072
Products in Payments
- VRAYLAR (Drug) $967.75
- FARXIGA (Drug) $865.78
- UBRELVY (Drug) $709.23
- TRADJENTA (Drug) $507.70
- ELIQUIS (Drug) $464.06
- Ozempic (Drug) $458.48
- EMGALITY (Drug) $446.79
- Vascepa (Drug) $418.46
- TRULICITY (Drug) $377.65
- FREESTYLE LIBRE 3 (Device) $371.85
- JARDIANCE (Drug) $365.37
- QULIPTA (Drug) $356.30
- XARELTO (Drug) $319.06
- NURTEC ODT (Drug) $314.93
- ENTRESTO (Drug) $305.74
- TRELEGY ELLIPTA (Drug) $270.88
- Victoza (Drug) $270.79
- BELSOMRA (Drug) $246.22
- Aimovig (Biological) $222.87
- Xofluza (Drug) $203.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.